Dose Matters: The Importance of Appropriate Dosing: A Case Report on Sunitinib Treatment in a Patient With Metastatic Renal Cell Carcinoma

被引：1
|
作者：
Bojic, Marija [1 ]
Schmidinger, Manuela [1 ]
机构：
[1] Med Univ Vienna, A-1090 Vienna, AT, Austria
来源：
CLINICAL GENITOURINARY CANCER | 2012年 / 10卷 / 04期
关键词：
Dosing; Metastatic renal cell carcinoma; Tyrosine kinase inhibitor; INTERFERON-ALPHA; PHASE-3; TRIAL;
D O I：
10.1016/j.clgc.2012.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [21] Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma
    Hiles, Jon J.
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (02) : 123 - 131
  • [22] Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma
    Cheng, Winnie
    Kletas, Victoria
    Kollmannsberger, Christian
    de Lemos, Mario
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 67 - 73
  • [23] SUNITINIB DOSING SCHEDULES IN THE MANAGEMENT OF METASTATIC RENAL CELL CARCINOMA: A META-ANALYSIS
    Abogunrin, S.
    Ashaye, A. O.
    Fahrbach, K.
    Cappelleri, J. C.
    Sandin, R.
    Ramaswamy, K.
    VALUE IN HEALTH, 2016, 19 (07) : A711 - A711
  • [24] An alternative dosage form of sunitinib in a patient with metastatic renal cell carcinoma
    Zolnierek, Jakub
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A31 - A32
  • [25] Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma
    Yildiz, Ibrahim
    Varol, Umut
    Sen, Fatma
    Kilic, Leyla
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (07): : 654 - 656
  • [26] Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
    Edeline, J.
    Laguerre, B.
    Rolland, Y.
    Patard, J. -J.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 186 - 187
  • [27] CAN DOSE ALTERNATING OF SUNITINIB REGIMEN ENHANCE PATIENT'S OUTCOMES AS A FIRST LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA?
    Abotaleb, A.
    VALUE IN HEALTH, 2017, 20 (05) : A110 - A110
  • [28] Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
    Gomez-Abuin, Gonzalo
    Amelia Karam, Aida
    Aristides Mezzadri, Norberto
    Arturo Bas, Carlos
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 62 - 63
  • [29] Biochemical and Pathological Response of Prostate Cancer in a Patient with Metastatic Renal Cell Carcinoma on Sunitinib Treatment
    Song, Ik Chan
    Lim, Jae Sung
    Yun, Hwan Jung
    Kim, Samyong
    Kang, Dae Young
    Lee, Hyo Jin
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (12) : 833 - 836
  • [30] Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report
    Morita, Jun
    Naoe, Michio
    Ogawa, Yu
    Nakasato, Takehiko
    Sugahara, Motoko
    Morita, Masashi
    Fuji, Kohzo
    Fukagai, Takashi
    Sasaki, Haruaki
    Ogawa, Yoshio
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (5-6): : E351 - E354
12345